Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 48Leukemia 46Anemia, Refractory, with Excess of Blasts 43Leukemia, Myeloid, Acute 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia, Myelomonocytic, Chronic 29Leukemia, Myeloid, Chronic-Phase 26Lymphoma 25Myeloproliferative Disorders 22Multiple Myeloma 22Lymphoma, Non-Hodgkin 21Leukemia, Myeloid, Accelerated Phase 21Congenital Abnormalities 21Leukemia, Lymphocytic, Chronic, B-Cell 20Blast Crisis 20Anemia, Refractory 20Burkitt Lymphoma 17Myelodysplastic-Myeloproliferative Diseases 16Hodgkin Disease 16Primary Myelofibrosis 15Lymphoma, Follicular 15Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15Dendritic Cell Sarcoma, Interdigitating 14Anemia, Aplastic 14Neoplasms, Plasma Cell 13Lymphoma, Mantle-Cell 13Lymphoma, Large-Cell, Immunoblastic 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, B-Cell, Marginal Zone 13Recurrence 11

Interventions

Radiotherapy 1Methylprednisolone 1Melphalan 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymoma × Busulfan × Classical hematology × Clear all
NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Roswell Park Cancer Institute

Phase 2 Completed
90 enrolled
Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡